1. 04.04 Suramin protects against osteoarthritis by increasing tissue inhibitor of matrix metalloproteinase-3 and glycosaminoglycans in the articular cartilage. (1st March 2017) Authors: Guns, Laura-An; Kvasnytsia, Maryna; Kerckhofs, Greet; Vandooren, Jennifer; Martens, Erik; Opdenakker, Ghislain; Lories, Rik J; Cailotto, Frédéric Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 1 Page Start: A42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A5.6 Cholecystokinin and purinoreceptor antagonists modulate OA-associated GPR22 signalling. (31st January 2014) Authors: Guns, Laura-An; Cailotto, Frédéric; Lories, Rik J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 1(2014) Page Start: A65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Suramin increases cartilage proteoglycan accumulation in vitro and protects against joint damage triggered by papain injection in mouse knees in vivo. Issue 2 (30th November 2017) Authors: Guns, Laura-An; Monteagudo, Silvia; Kvasnytsia, Maryna; Kerckhofs, Greet; Vandooren, Jennifer; Opdenakker, Ghislain; Lories, Rik J; Cailotto, Frederic Journal: RMD open Issue: Volume 3:Issue 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗